treatment necessitates observation-for example, an annual examination by biomicroscopy of the cornea. It might also be prudent to review retinal function (colour vision and electroretinography) in patients taking flecainide. 1
No takes yet. Share an insight, caveat, or question.
Lip et al. (1991) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: